(Reuters) - Japanese drugmaker Otsuka Holdings Co Ltd plans to buy U.S.-based Avanir Pharmaceuticals Inc for about $3.5 billion (2.2 billion pounds) to expand its neurologic drug portfolio ahead of an ...
0 commentaires:
Enregistrer un commentaire